Pediatrix Medical Group, Inc. Financial Ratios — MD Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	13.72	12.79	12.81	13.77	14.3	12.5	11	8.73	-65.3	-70.91	15.93	7.42	-6.94	-12.28	20.28
Return on Assets (%)	10.12	9.59	9.74	9.59	8.25	6.57	5.72	4.55	-29.71	-21.26	4.31	2.62	-2.65	-4.53	7.52
Return on Capital (%)	13.13	12.33	12.48	12.41	10.73	8.93	8.09	6.74	-33.81	-32.32	8.23	5.42	- -	- -	13.18
Return on Invested Capital (%)	15.42	17.02	17.02	16.93	14.67	12.04	10.11	4.85	5.84	-12.23	13.13	23.21	- -	- -	18.29
Gross Margin (%)	34.69	33.79	32.98	33.07	33.38	32.47	28.27	29.31	28.27	25.91	26.85	23.68	21.13	22.57	25.8
EBITDA Margin (%)	23.97	23.14	22.85	22.92	22.38	20.76	16.41	15.83	14.53	11.56	13.07	11.95	9.73	10.73	13.21
Operating Margin (%)	22.38	21.44	20.99	21.03	20.07	17.96	13.98	14.42	13.07	9.92	11.39	10.14	7.91	9.13	12.07
Incremental Operating Margin (%)	22.75	14.95	18.56	21.36	13.15	3.43	-166.3	13.49	-27.79	132.54	25.84	-29.16	-186.34	141.3	-47.85
Pretax Margin (%)	22.24	21.37	20.82	20.85	19.41	16.14	11.85	9.65	3.3	0.41	7.08	4.13	-2.42	-5.03	11.31
Profit Margin (%)	13.73	13.26	13.02	13.01	12.1	10.21	9.85	15.59	-84.15	-45.93	6.85	3.36	-3.03	-4.92	8.64
Net Income to Common Margin (%)	13.73	13.26	13.02	13.01	12.1	10.21	9.85	15.59	-84.15	-45.93	6.85	3.36	-3.03	-4.92	8.64
Effective Tax Rate (%)	38.29	37.94	37.44	37.63	37.8	36.82	20.8	26.89	28.2	234.02	20.14	23.11	- -	- -	23.58
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	13.72	12.79	12.81	13.77	14.3	12.5	11	8.73	-65.3	-70.91	15.93	7.42	-6.94	-12.28	20.28

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	29	144	27	569	1,275	1,706	1,853	1,975	1,793	1,805	1,066	717	702	662	635
ST Debt	- -	- -	- -	10	12	22	1	- -	18	21	22	36	36	33	38
LT Debt	29	144	27	558	1,263	1,684	1,851	1,974	1,775	1,784	1,044	681	666	629	596
Total Debt/EBITDA	0.08	0.34	0.06	1.02	2.05	2.58	3.47	7.24	6.93	9.01	4.27	3.04	3.62	3.07	2.51
Net Debt/EBITDA	0.03	0.29	-0.01	0.93	1.96	2.5	3.36	7.14	6.27	3.04	2.46	2.68	2.84	1.77	0.86
Total Debt/EBIT	0.08	0.37	0.06	1.11	2.28	2.98	4.07	7.95	7.71	10.5	4.9	3.59	4.44	3.61	2.75
Net Debt/EBIT	0.03	0.32	-0.01	1.01	2.18	2.89	3.94	7.84	6.97	3.55	2.82	3.15	3.49	2.08	0.95
EBITDA to Interest Expense	104.61	129.53	90.88	62.87	26.92	10.48	7.16	2.93	2.17	1.81	3.64	5.94	4.61	5.3	7.03
EBITDA-CapEx/Interest Expense	96	125.07	87.99	60.84	25.75	9.85	6.81	2.75	2.01	1.55	3.17	5.19	3.82	4.76	6.52
EBIT to Interest Expense	97.66	120.04	83.5	57.7	24.14	9.06	6.1	2.67	1.96	1.56	3.17	5.04	3.75	4.51	6.43
Interest Expense	4	3	5	9	23	63	75	93	119	110	69	40	42	41	36
Common Equity/Total Assets	76.17	74	77.87	62.76	53.6	51.71	52.26	52.01	36.16	22.33	32.93	37.98	38.25	35.53	38.54
Long-Term Debt/Equity (%)	1.69	7.09	1.16	24.64	51.8	60.98	60.38	63.94	118.4	238.53	116.39	76.33	78.4	82.24	68.86
Long-Term Debt/Capital (%)	1.67	6.62	1.15	19.7	34.01	37.7	37.64	39	53.91	69.88	53.18	42.31	42.93	44.08	39.74
Long-Term Debt/Total Assets (%)	1.29	5.24	0.9	15.47	27.77	31.53	31.56	33.25	42.81	53.27	38.33	28.99	29.99	29.22	26.54
Total Debt/Equity (%)	1.7	7.09	1.16	25.11	52.29	61.78	60.42	63.94	119.62	241.36	118.86	80.42	82.64	86.58	73.29
Total Debt/Capital (%)	1.67	6.62	1.15	20.07	34.33	38.19	37.66	39	54.47	70.71	54.31	44.57	45.25	46.4	42.29
Total Debt/Total Assets (%)	1.3	5.25	0.91	15.76	28.03	31.95	31.58	33.26	43.25	53.9	39.15	30.54	31.61	30.77	28.25
Net Debt to Equity	0.6	6.03	-0.17	22.97	50	59.77	58.46	63.1	108.23	81.56	68.57	70.69	64.88	49.99	25.26
Net Debt/Capital (%)	0.6	5.69	-0.17	18.68	33.29	37.41	36.89	38.69	50.95	42.69	39.04	39.42	37.28	31.94	19.44
EBITDA	381	420	492	559	622	661	534	273	259	200	250	236	194	216	253
EBITDA-CapEx	349	406	476	541	595	622	508	256	239	172	218	206	161	194	234
Operating Income (Loss)	355	390	452	513	558	572	455	248	233	172	218	200	158	184	231

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.09	0.1	0.12	0.13	0.14	0.15	0.13	0.09	0.34	2.77	1.14	0.24	0.46	0.8	1.09
Current Ratio	1.33	1.34	1.13	1.12	1.23	1.31	1.18	1.31	1.35	3.49	1.97	1	1.24	1.47	1.66
Quick Ratio	1	1.03	0.99	0.98	1.18	1.25	1.08	1.1	1.14	3.31	1.88	0.94	1.18	1.43	1.62
CFO/Avg Current Liab	0.94	1.24	1.36	1.14	0.87	1.01	1.04	0.61	0.68	0.41	0.18	0.39	0.34	0.5	0.61
Common Equity/Total Assets	76.17	74	77.87	62.76	53.6	51.71	52.26	52.01	36.16	22.33	32.93	37.98	38.25	35.53	38.54
Long-Term Debt/Equity (%)	1.69	7.09	1.16	24.64	51.8	60.98	60.38	63.94	118.4	238.53	116.39	76.33	78.4	82.24	68.86
Long-Term Debt/Capital (%)	1.67	6.62	1.15	19.7	34.01	37.7	37.64	39	53.91	69.88	53.18	42.31	42.93	44.08	39.74
Long-Term Debt/Total Assets (%)	1.29	5.24	0.9	15.47	27.77	31.53	31.56	33.25	42.81	53.27	38.33	28.99	29.99	29.22	26.54
Total Debt/Equity (%)	1.7	7.09	1.16	25.11	52.29	61.78	60.42	63.94	119.62	241.36	118.86	80.42	82.64	86.58	73.29
Total Debt/Capital (%)	1.67	6.62	1.15	20.07	34.33	38.19	37.66	39	54.47	70.71	54.31	44.57	45.25	46.4	42.29
Total Debt/Total Assets (%)	1.3	5.25	0.91	15.76	28.03	31.95	31.58	33.26	43.25	53.9	39.15	30.54	31.61	30.77	28.25
CFO/Total Liabilities	49.97	45.44	60.9	31.48	17.48	17.21	18.26	11.01	13.51	7.87	4.2	11.46	10.02	14.89	19.63
CFO/CapEx	8.64	22.42	25.9	23.4	13.62	11.3	19.56	18.32	18.56	7.11	2.38	5.62	4.12	9.38	14.69
Altman's Z-Score	12.02	11.82	14.26	12.49	10.97	10.82	9.27	4.23	1.85	2.24	3.21	3.65	3.31	3.29	3.79

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	7.71	7.59	8.08	7.65	6.98	6.77	6.51	3.41	3.78	5.13	7.03	6.59	7.01	7.56	7.82
Days Sales Outstanding	47.32	48.07	45.2	47.71	52.32	53.89	56.05	107.05	96.49	71.17	51.92	55.39	52.07	48.26	46.69
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	94.96	92.25	89.07	63.53	67.65	85.23	73.96	37.09	38.41	26.99	29	43.94	47.35	38.47	33.95
Accounts Payable Turnover Days	3.84	3.96	4.1	5.75	5.4	4.28	4.93	9.84	9.5	13.52	12.59	8.31	7.71	9.49	10.75
Cash Conversion Cycle	43.47	44.11	41.1	41.96	46.92	49.61	51.12	97.21	86.99	57.65	39.33	47.09	44.36	38.77	35.94
Inventory to Cash Days	47.32	48.07	45.2	47.71	52.32	53.89	56.05	107.05	96.49	71.17	51.92	55.39	52.07	48.26	46.69
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	3,524	3,978	5,402	6,349	6,717	6,247	5,008	2,898	2,341	2,100	2,352	1,233	781	1,127	1,775
- Cash & Cash Equivalents	19	21	31	48	52	56	60	25	108	1,124	387	10	73	230	375
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	29	144	27	569	1,275	1,706	1,853	1,975	1,793	1,805	1,066	717	702	662	635
Enterprise Value	3,530	4,094	5,392	6,864	7,932	7,886	6,791	4,825	3,952	2,677	2,930	1,847	1,305	1,440	1,910
Total Capital	1,760	2,180	2,370	2,834	3,713	4,466	4,919	5,062	3,292	2,552	1,963	1,609	1,551	1,427	1,500
Total Debt/Capital (%)	1.67	6.62	1.15	20.07	34.33	38.19	37.66	39	54.47	70.71	54.31	44.57	45.25	46.4	42.29
Total Debt / EV	0.01	0.04	0.01	0.08	0.16	0.22	0.27	0.41	0.45	0.67	0.36	0.39	0.54	0.46	0.33
EV/Sales	2.22	2.25	2.5	2.81	2.85	2.48	2.09	2.8	2.22	1.54	1.53	0.94	0.65	0.72	1
EV/EBITDA	9.27	9.74	10.96	12.28	12.75	11.93	12.72	17.69	15.28	13.36	11.73	7.84	6.73	6.67	7.55
EV/EBIT	9.93	10.51	11.93	13.38	14.22	13.79	14.93	19.43	16.99	15.57	13.46	9.23	8.27	7.84	8.26
EV/Cash Flow to Firm	12.94	12.52	13.19	16.03	20.71	16.31	11.9	12.64	8.92	47.33	22.27	9.35	6.87	5.85	6.4
EV/Free Cash Flow to Firm	11.6	11.99	12.7	15.38	19.34	15.08	11.38	12.1	8.55	31.37	17.88	8.13	5.85	5.37	6.02
Diluted Market Cap	3,524	3,978	5,402	6,604	6,733	6,247	5,008	3,023	2,341	2,100	2,352	1,250	781	1,127	1,824
Diluted Enterprise Value	3,535	4,101	5,399	7,125	7,957	7,897	6,801	4,972	4,027	2,782	3,030	1,957	1,410	1,559	2,083
EV per Share	36.07	40.92	53.28	71.48	84.62	84.15	72.46	54.94	46.91	31.27	33.91	22.26	15.54	16.77	23.02
TTM Sales	1,588	1,817	2,154	2,439	2,780	3,183	3,253	1,723	1,780	1,734	1,911	1,972	1,995	2,013	1,914
TTM EBITDA	381	420	492	559	622	661	534	273	259	200	250	236	194	216	253
TTM Operating Income	355	390	452	513	558	572	455	248	233	172	218	200	158	184	231
TTM Cash Flow to Firm	273	327	409	428	383	484	570	382	443	57	132	197	190	246	299
TTM Free Cash Flow to Firm	304	341	424	446	410	523	597	399	462	85	164	227	223	268	317

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	11.67	11.72	12.83	14.98	17.01	12.93	9.32	9.14	6.21	9	21.58	6.36	4.58	4.93	6.3
EV/EBIT	9.93	10.51	11.93	13.38	14.22	13.79	14.93	19.43	16.99	15.57	13.46	9.23	8.27	7.84	8.26
Enterprise Value	3,530	4,094	5,392	6,864	7,932	7,886	6,791	4,825	3,952	2,677	2,930	1,847	1,305	1,440	1,910
Low Price	29.24	29.62	40.33	49.82	64.12	59.36	40.56	31.68	19.93	7.37	20.27	14.4	8.18	6.62	11.84
EV/Sales	2.22	2.25	2.5	2.81	2.85	2.48	2.09	2.8	2.22	1.54	1.53	0.94	0.65	0.72	1
EV/EBITDA	9.27	9.74	10.96	12.28	12.75	11.93	12.72	17.69	15.28	13.36	11.73	7.84	6.73	6.67	7.55
Price/Earnings	16.16	16.51	19.26	20.01	19.97	19.23	15.63	10.79	- -	- -	17.96	18.58	- -	- -	10.73
Price/Earnings Average	15.13	14.72	17.18	17.77	20.65	19.37	16.33	15.42	-1.52	-1.96	18.55	25.4	-18.5	-8.86	7.97
Price/Earnings High	16.94	16.97	20.36	20.47	23.99	22.2	21.1	20.61	-2.19	-3	23.54	35.04	-24.06	-14.22	12.54
Price/Earnings Low	13.13	12.3	14.55	15.08	17.87	17.12	11.87	10.36	-1.12	-0.79	13.38	18.01	-11.38	-5.74	5.94
Price/Book Value	2.04	1.95	2.31	2.8	2.76	2.26	1.63	0.94	1.56	2.81	2.62	1.38	0.92	1.47	2.05
Price/Book Value Average	1.91	1.74	2.06	2.49	2.85	2.28	1.71	1.34	1.52	2.08	2.71	1.89	1.32	1.15	1.52
Price/Book Value High	2.13	2.01	2.44	2.87	3.31	2.61	2.2	1.79	2.19	3.19	3.44	2.61	1.71	1.84	2.39
Price/Book Value Low	1.65	1.46	1.74	2.11	2.47	2.02	1.24	0.9	1.12	0.84	1.95	1.34	0.81	0.74	1.13
Price/Tangible Book Value	-223.78	-30.52	-106.47	-8.95	-4.97	-3.56	-2.7	-2.25	-247.99	-2.77	-3.73	-1.87	-1.4	-2.3	-4.31
Price/Tangible Book Value Average	-209.47	-27.21	-94.98	-7.94	-5.13	-3.59	-2.82	-3.22	-240.84	-2.06	-3.85	-2.56	-2.01	-1.79	-3.2
Price/Tangible Book Value High	-234.53	-31.37	-112.58	-9.15	-5.97	-4.11	-3.64	-4.3	-347	-3.15	-4.89	-3.53	-2.61	-2.88	-5.04
Price/Tangible Book Value Low	-181.74	-22.74	-80.43	-6.74	-4.44	-3.17	-2.05	-2.16	-177.85	-0.83	-2.78	-1.81	-1.24	-1.16	-2.39
Price/Sales	2.22	2.19	2.51	2.6	2.42	1.96	1.54	1.68	1.32	1.21	1.23	0.63	0.39	0.56	0.93
Price/Sales Average	2.08	1.95	2.24	2.31	2.5	1.98	1.61	2.4	1.28	0.9	1.27	0.85	0.56	0.44	0.69
Price/Sales High	2.33	2.25	2.65	2.66	2.9	2.27	2.08	3.21	1.84	1.38	1.61	1.18	0.73	0.7	1.08
Price/Sales Low	1.8	1.63	1.89	1.96	2.16	1.75	1.17	1.61	0.94	0.36	0.92	0.61	0.34	0.28	0.51
Price/Cash Flow	13.02	12.24	13.33	15.02	18.22	14.08	9.79	9.24	6.55	10.27	30.64	7.38	5.69	5.45	6.55
Price/Cash Flow Average	12.19	10.91	11.89	13.34	18.84	14.18	10.23	13.2	6.36	7.61	31.67	10.09	8.14	4.25	4.86
Price/Cash Flow High	13.64	12.58	14.09	15.37	21.89	16.25	13.22	17.65	9.16	11.67	40.18	13.92	10.58	6.82	7.65
Price/Cash Flow Low	10.57	9.12	10.07	11.32	16.3	12.54	7.43	8.87	4.69	3.08	22.83	7.15	5	2.75	3.62
Price/Free Cash Flow Average	10.92	10.45	11.45	13.31	17.59	13.03	9.73	13.06	6.03	6.67	22.3	8.69	6.55	3.84	4.68
Price/Free Cash Flow High	12.23	12.04	13.57	15.33	20.44	14.93	12.58	17.46	8.69	10.23	28.29	11.99	8.52	6.16	7.36
Price/Free Cash Flow Low	9.48	8.73	9.69	11.29	15.22	11.52	7.07	8.77	4.45	2.7	16.07	6.16	4.03	2.49	3.49
EV/Sales Average	2.08	2.02	2.24	2.53	2.94	2.5	2.16	3.53	2.22	1.29	1.63	1.21	0.88	0.65	0.82
EV/Sales High	2.33	2.32	2.65	2.88	3.34	2.78	2.63	4.34	2.79	1.77	1.97	1.54	1.04	0.91	1.22
EV/Sales Low	1.81	1.7	1.89	2.18	2.6	2.27	1.72	2.75	1.89	0.76	1.27	0.96	0.66	0.5	0.65
EV/EBITDA Average	8.69	8.73	9.79	11.02	13.13	12.02	13.16	22.33	15.31	11.17	12.44	10.15	9	6.07	6.24
EV/EBITDA High	9.73	10.02	11.6	12.55	14.94	13.41	16.02	27.44	19.19	15.32	15.05	12.86	10.73	8.53	9.22
EV/EBITDA Low	7.55	7.34	8.29	9.49	11.63	10.91	10.48	17.35	13.01	6.55	9.73	8.07	6.78	4.64	4.91
EV/EBIT Average	9.31	9.42	10.65	12.01	14.64	13.89	15.44	24.52	17.02	13.02	14.28	11.96	11.06	7.13	6.83
EV/EBIT High	10.42	10.81	12.63	13.68	16.66	15.5	18.8	30.14	21.33	17.85	17.28	15.16	13.19	10.03	10.1
EV/EBIT Low	8.08	7.92	9.02	10.34	12.97	12.62	12.3	19.05	14.46	7.63	11.16	9.51	8.33	5.45	5.37
Last Price	36.01	39.76	53.38	66.11	71.66	66.66	53.44	33	27.79	24.54	27.21	14.86	9.3	13.12	21.39
High Price	37.74	40.86	56.44	67.64	86.09	76.96	72.13	63.04	38.88	27.9	35.67	28.02	17.3	16.41	24.99
Enterprise Value Average	3,309	3,668	4,816	6,159	8,170	7,943	7,023	6,090	3,959	2,239	3,109	2,392	1,746	1,310	1,578
Enterprise Value High	3,704	4,211	5,709	7,017	9,293	8,863	8,553	7,485	4,961	3,069	3,762	3,031	2,082	1,841	2,333
Enterprise Value Low	2,872	3,086	4,077	5,306	7,234	7,213	5,594	4,731	3,364	1,312	2,430	1,902	1,316	1,001	1,242

Shares Outstanding	98	100	101	96	94	94	94	88	84	86	86	83	84	86	83
Diluted Weighted Avg Shares	98	100	101	100	94	94	94	92	84	86	86	84	84	86	85
Basic Weighted Avg Shares	98	100	101	96	94	94	94	88	84	86	86	83	84	86	83
Revenue per Share	16.23	18.16	21.28	25.4	29.66	33.97	34.71	19.62	21.13	20.26	22.11	23.77	23.74	23.44	23.07
EBITDA per Share	3.89	4.2	4.86	5.82	6.64	7.05	5.7	3.11	3.07	2.34	2.89	2.84	2.31	2.51	3.05
Operating Income per Share	3.63	3.89	4.47	5.34	5.95	6.1	4.85	2.83	2.76	2.01	2.52	2.41	1.88	2.14	2.78
Basic EPS, GAAP	2.23	2.41	2.77	3.3	3.59	3.47	3.42	3.06	-17.78	-9.31	1.52	0.8	-0.72	-1.15	1.99
Basic EPS from Cont Ops	2.23	2.41	2.77	3.3	3.58	3.46	3.26	1.38	0.5	-0.11	1.25	0.75	-0.72	-1.15	1.99
Diluted EPS, GAAP	2.23	2.41	2.77	3.18	3.58	3.47	3.42	2.93	-17.78	-9.31	1.52	0.79	-0.72	-1.15	1.94
Diluted EPS from Cont Ops	2.23	2.41	2.77	3.18	3.57	3.46	3.26	1.33	0.5	-0.11	1.25	0.74	-0.72	-1.15	1.94
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	2.77	3.25	4.01	4.4	3.93	4.74	5.46	3.57	4.25	2.39	0.89	2.01	1.63	2.41	3.27
Free Cash Flow per Basic Share	2.45	3.1	3.85	4.21	3.64	4.32	5.18	3.38	4.02	2.05	0.51	1.65	1.24	2.15	3.04
Cash & Equivalents per Share	0.23	0.28	0.37	0.56	0.64	0.71	0.75	0.54	2.16	14.36	5.64	1.24	2.12	4.06	6.02
Book Value per Share	17.69	20.35	23.15	23.58	26	29.46	32.72	35.16	17.79	8.73	10.37	10.75	10.11	8.91	10.43
Tangible Book Value per Share	-0.16	-1.3	-0.5	-7.39	-14.43	-18.7	-19.82	-14.65	-0.11	-8.85	-7.3	-7.94	-6.62	-5.7	-4.96

Pediatrix Medical Group, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)